electroCore, Inc. (ECOR) Receives Consensus Recommendation of “Strong Buy” from Brokerages
electroCore, Inc. (NASDAQ:ECOR) has earned a consensus broker rating score of 1.00 (Strong Buy) from the four analysts that cover the company, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.
Analysts have set a twelve-month consensus price target of $21.25 for the company, according to Zacks. Zacks has also given electroCore an industry rank of 100 out of 256 based on the ratings given to related companies.
Several equities analysts recently weighed in on ECOR shares. Zacks Investment Research lowered electroCore from a “hold” rating to a “sell” rating in a research note on Friday, April 26th. Noble Financial started coverage on electroCore in a research note on Wednesday, May 8th. They issued an “outperform” rating and a $19.00 price target for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $19.00 price target (down previously from $23.00) on shares of electroCore in a research note on Wednesday. Finally, BTIG Research lowered electroCore from a “buy” rating to a “neutral” rating in a research note on Wednesday.
electroCore (NASDAQ:ECOR) last released its quarterly earnings data on Tuesday, May 14th. The company reported ($0.47) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.54) by $0.07. As a group, equities research analysts forecast that electroCore will post -2.18 EPS for the current year.
In related news, insider Joseph P. Errico sold 39,592 shares of electroCore stock in a transaction dated Friday, April 12th. The stock was sold at an average price of $5.52, for a total value of $218,547.84. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Joseph P. Errico sold 10,408 shares of electroCore stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $6.97, for a total value of $72,543.76. The disclosure for this sale can be found here.
A number of hedge funds have recently bought and sold shares of ECOR. BlackRock Inc. acquired a new position in shares of electroCore during the 3rd quarter worth approximately $3,862,000. Suffolk Capital Management LLC raised its position in shares of electroCore by 26.6% during the 4th quarter. Suffolk Capital Management LLC now owns 40,972 shares of the company’s stock valued at $256,000 after buying an additional 8,604 shares during the period. Wsfs Capital Management LLC purchased a new stake in electroCore in the fourth quarter valued at approximately $63,000. Vanguard Group Inc purchased a new stake in electroCore in the third quarter valued at approximately $1,988,000. Finally, Vanguard Group Inc. purchased a new stake in electroCore in the third quarter valued at approximately $1,988,000. Institutional investors own 14.09% of the company’s stock.
electroCore Company Profile
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: Cost of Debt
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.